fluorouracil has been researched along with HPV Infection in 58 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of 1% and 5% 5-fluorouracil (5-FU) creams compared with 90% trichloroacetic acid (TCA) for the treatment of anogenital warts." | 5.34 | Randomised controlled trial of 1% and 5% 5-fluorouracil creams compared with 90% trichloroacetic acid solution for anogenital wart treatment. ( Anggraini, I; Hoemardani, AS; Indriatmi, W; Nilasari, H, 2020) |
| "Sixty-two females and 21 males were treated for recurrent HPV infection, with either fluorouracil (Efudex 5%) cream or laser ablation of the lesions." | 5.08 | Interferon as an adjuvant treatment for genital condyloma acuminatum. ( Bergman, A; Klutke, JJ, 1995) |
| "The authors established a protocol for the use of 5-fluorouracil (5FU) adjuvant in lasertherapy for clinical and subclinical HPV infection in immunosuppressed patients, persistent lesions and as reinforcement treatment in cases of poor progress." | 3.72 | Low-dose 5-fluorouracil adjuvant in laser therapy for HPV lesions in immunosuppressed patients and cases of difficult control. ( Costa, RR; Focchi, J; Freitas, VG; Kesselring, F; Ribalta, JC; Speck, NM, 2004) |
| " The areas of debate and development include the dosing and timing of MMC delivery, the role of cisplatin chemotherapy as an alternative to MMC, the replacement of the standard 96-h infusion of 5FU with oral capecitabine, the use of targeted chemotherapy agents, and the duration and dose of RT." | 2.53 | Advances in the Management of Anal Cancer. ( Goodman, KA; Julie, DR, 2016) |
| "The majority of anal cancers are squamous cell carcinomas, and they are treated according to stage." | 2.52 | Anal cancer treatment: current status and future perspectives. ( Abdayem, P; Antoun, J; Ghosn, M; Kourie, HR; Nasr, D, 2015) |
| "Head and neck squamous cell carcinoma is now the 8th most common cancer affecting men in the United States largely due to a rising epidemic of oropharynx cancer (tonsil and tongue base) associated with the human papillomavirus (HPV)." | 2.48 | Current treatment options for metastatic head and neck cancer. ( Cohen, EE; Price, KA, 2012) |
| "The treatment of genital warts remains frustrating since it is often painful, expensive, and unsuccessful." | 2.39 | Human papillomavirus infection and genital warts: update on epidemiology and treatment. ( Stone, KM, 1995) |
| "Distant metastases (DM) are a leading cause of death for patients with oropharyngeal cancer (OPSCC)." | 1.51 | The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting. ( Griffiths, RJ; Hall, SF; Liu, FF; O'Sullivan, B, 2019) |
| "Anal cancer is uncommon." | 1.42 | Review of anal cancer patients at the Ottawa hospital. ( Abunassar, M; Asmis, T; Jonker, DJ; Reinders, J, 2015) |
| "Head and neck squamous cell carcinoma (HNSCC) is the sixth most common type of cancer worldwide." | 1.40 | Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro. ( Aderhold, C; Faber, A; Hoermann, K; Hofheinz, RD; Sauter, A; Schultz, JD; Stern-Straeter, J; Umbreit, C, 2014) |
| "Head and neck squamous cell carcinoma (HNSCC) is the most common malignant epithelial tumor in the upper aerodigestive tract." | 1.39 | Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro. ( Aderhold, C; Birk, R; Erben, P; Faber, A; Hofheinz, RD; Hörmann, K; Sauter, A; Schultz, JD; Sommer, JU; Stern-Straeter, J; Umbreit, C, 2013) |
| "Head and neck squamous cell carcinoma (HNSCC) is the sixth most common type of cancer worldwide." | 1.39 | Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro. ( Aderhold, C; Faber, A; Hoermann, K; Hofheinz, RD; Sauter, A; Schultz, JD; Sommer, JU; Stern-Sträter, J; Umbreit, C, 2013) |
| "For the 83 patients with HPV 16-cancer of the cervix (cervical cancer) I-III stages it was performed a comparative analysis of primary tumor response to therapy, the clinical outcome of the disease for 3-5 years after radical treatment and an evaluation of the possible contribution in these rates of the physical status of the virus." | 1.39 | [The significance of physical status of human papillomavirus type 16 for predicting the effectiveness of invasive cervical cancer treatment]. ( Beziaeva, GP; Kiseleva, VI; Krikunova, LI; Liubina, LV; Mkrtchian, LS; Panarina, LV; Saenko, AS; Zamulaeva, IA, 2013) |
| "The optimal management of oropharyngeal squamous cell carcinoma (OPSCC) is controversial." | 1.38 | Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy. ( Annino, DJ; Balboni, TA; Goguen, LA; Haddad, RI; Lorch, J; Norris, CM; Posner, MR; Sher, DJ; Thotakura, V; Tishler, RB, 2012) |
| "DNA was extracted from 26 oesophageal cancer patients undergoing CRX and surgery." | 1.33 | [HPV-infection in esophageal cancer as possible predictive factor after neoadjuvant therapy]. ( Gábor, B; György, L; Imdahl, A; Pál, O, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (20.69) | 18.2507 |
| 2000's | 11 (18.97) | 29.6817 |
| 2010's | 31 (53.45) | 24.3611 |
| 2020's | 4 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Desravines, N | 1 |
| Hsu, CH | 1 |
| Mohnot, S | 1 |
| Sahasrabuddhe, V | 1 |
| House, M | 1 |
| Sauter, E | 1 |
| O'Connor, S | 1 |
| Bauman, JE | 1 |
| Chow, HS | 1 |
| Rahangdale, L | 1 |
| Anggraini, I | 1 |
| Hoemardani, AS | 1 |
| Nilasari, H | 1 |
| Indriatmi, W | 1 |
| Mezi, S | 1 |
| Pomati, G | 1 |
| Botticelli, A | 1 |
| Roberto, M | 1 |
| Cerbelli, B | 1 |
| Cirillo, A | 1 |
| Di Gioia, C | 1 |
| Corsi, A | 1 |
| Vullo, F | 1 |
| De Vincentiis, M | 1 |
| Polimeni, A | 1 |
| Tombolini, V | 1 |
| Valentini, V | 1 |
| Marchetti, P | 1 |
| Spehner, L | 1 |
| Kim, S | 2 |
| Vienot, A | 1 |
| François, E | 1 |
| Buecher, B | 1 |
| Adotevi, O | 1 |
| Vernerey, D | 1 |
| Abdeljaoued, S | 1 |
| Meurisse, A | 1 |
| Borg, C | 2 |
| Glynne-Jones, R | 1 |
| Bollo, J | 1 |
| Balla, A | 1 |
| Rodriguez Luppi, C | 1 |
| Martinez, C | 1 |
| Quaresima, S | 1 |
| Targarona, EM | 1 |
| Uzunçakmak, TK | 1 |
| Cebeci, F | 1 |
| Dağdelen, D | 1 |
| Gürel, MS | 1 |
| Zenginkinet, T | 1 |
| Akdeniz, N | 1 |
| Haddad, RI | 3 |
| Massarelli, E | 1 |
| Lee, JJ | 1 |
| Lin, HY | 1 |
| Hutcheson, K | 1 |
| Lewis, J | 1 |
| Garden, AS | 1 |
| Blumenschein, GR | 1 |
| William, WN | 1 |
| Pharaon, RR | 1 |
| Tishler, RB | 2 |
| Glisson, BS | 1 |
| Pickering, C | 1 |
| Gold, KA | 1 |
| Johnson, FM | 1 |
| Rabinowits, G | 1 |
| Ginsberg, LE | 1 |
| Williams, MD | 1 |
| Myers, J | 1 |
| Kies, MS | 1 |
| Papadimitrakopoulou, V | 1 |
| Killock, D | 1 |
| Hall, SF | 1 |
| Griffiths, RJ | 1 |
| O'Sullivan, B | 1 |
| Liu, FF | 1 |
| Aderhold, C | 3 |
| Umbreit, C | 3 |
| Faber, A | 3 |
| Sauter, A | 3 |
| Sommer, JU | 2 |
| Birk, R | 1 |
| Erben, P | 1 |
| Hofheinz, RD | 3 |
| Stern-Straeter, J | 2 |
| Hörmann, K | 1 |
| Schultz, JD | 3 |
| Stern-Sträter, J | 1 |
| Hoermann, K | 2 |
| Jary, M | 1 |
| Mansi, L | 1 |
| Benzidane, B | 1 |
| Cazorla, A | 1 |
| Demarchi, M | 1 |
| Nguyen, T | 1 |
| Kaliski, A | 1 |
| Delabrousse, E | 1 |
| Bonnetain, F | 1 |
| Letondal, P | 1 |
| Bosset, JF | 1 |
| Valmary-Degano, S | 1 |
| Bejarano, PA | 1 |
| Boutros, M | 1 |
| Berho, M | 1 |
| Bossi, P | 1 |
| Orlandi, E | 1 |
| Miceli, R | 1 |
| Perrone, F | 1 |
| Guzzo, M | 1 |
| Mariani, L | 1 |
| Granata, R | 1 |
| Locati, L | 1 |
| Fallai, C | 1 |
| Cortelazzi, B | 1 |
| Pilotti, S | 1 |
| Scaramellini, G | 1 |
| Gloghini, A | 1 |
| Licitra, L | 1 |
| Kiseleva, VI | 1 |
| Krikunova, LI | 1 |
| Mkrtchian, LS | 1 |
| Liubina, LV | 1 |
| Beziaeva, GP | 1 |
| Panarina, LV | 1 |
| Saenko, AS | 1 |
| Zamulaeva, IA | 1 |
| Casadei Gardini, A | 1 |
| Capelli, L | 1 |
| Ulivi, P | 1 |
| Giannini, M | 1 |
| Freier, E | 1 |
| Tamberi, S | 1 |
| Scarpi, E | 1 |
| Passardi, A | 1 |
| Zoli, W | 1 |
| Ragazzini, A | 1 |
| Amadori, D | 1 |
| Frassineti, GL | 1 |
| Rödel, F | 2 |
| Wieland, U | 3 |
| Fraunholz, I | 1 |
| Kitz, J | 2 |
| Rave-Fränk, M | 2 |
| Wolff, HA | 1 |
| Weiss, C | 1 |
| Wirtz, R | 1 |
| Balermpas, P | 2 |
| Fokas, E | 2 |
| Rödel, C | 2 |
| Hasegawa, M | 1 |
| Maeda, H | 1 |
| Deng, Z | 1 |
| Kiyuna, A | 1 |
| Ganaha, A | 1 |
| Yamashita, Y | 1 |
| Matayoshi, S | 1 |
| Agena, S | 1 |
| Toita, T | 1 |
| Uehara, T | 1 |
| Suzuki, M | 1 |
| Ghosn, M | 1 |
| Kourie, HR | 1 |
| Abdayem, P | 1 |
| Antoun, J | 1 |
| Nasr, D | 1 |
| Abunassar, M | 1 |
| Reinders, J | 1 |
| Jonker, DJ | 1 |
| Asmis, T | 1 |
| Borycka-Kiciak, K | 1 |
| Białas, A | 1 |
| Wejman, J | 1 |
| Uchman-Musielak, M | 1 |
| Tarnowski, W | 1 |
| Belgioia, L | 1 |
| Vagge, S | 1 |
| Agnese, D | 1 |
| Garelli, S | 1 |
| Murialdo, R | 1 |
| Fornarini, G | 1 |
| Chiara, S | 1 |
| Gallo, F | 1 |
| Bacigalupo, A | 1 |
| Corvò, R | 1 |
| Mai, S | 1 |
| Welzel, G | 1 |
| Ottstadt, M | 1 |
| Lohr, F | 1 |
| Severa, S | 1 |
| Prigge, ES | 1 |
| Wentzensen, N | 1 |
| Trunk, MJ | 1 |
| Wenz, F | 1 |
| von Knebel-Doeberitz, M | 1 |
| Reuschenbach, M | 1 |
| Julie, DR | 1 |
| Goodman, KA | 1 |
| Dang, RP | 1 |
| LE, VH | 1 |
| Miles, BA | 1 |
| Teng, MS | 1 |
| Genden, EM | 1 |
| Bakst, RL | 1 |
| Gupta, V | 1 |
| Zhang, DY | 1 |
| Demicco, EG | 1 |
| Posner, MR | 2 |
| Misiukiewicz, KJ | 1 |
| Martin, D | 1 |
| Helmke, C | 1 |
| Matthess, Y | 1 |
| Raab, M | 1 |
| Strebhardt, K | 1 |
| Gammon, DC | 1 |
| Reed, KA | 1 |
| Patel, M | 1 |
| Balaji, KC | 1 |
| Lindel, K | 1 |
| Helmke, B | 1 |
| Simon, C | 1 |
| Weber, KJ | 1 |
| Debus, J | 1 |
| de Villiers, EM | 1 |
| Hill, J | 1 |
| Paczos, TA | 1 |
| Ackers, S | 1 |
| Odunsi, K | 1 |
| Lele, S | 1 |
| Mhawech-Fauceglia, P | 1 |
| Maillard, S | 1 |
| Merol, JC | 1 |
| Chays, A | 1 |
| Nguyen, TD | 1 |
| Richel, O | 1 |
| de Vries, HJ | 1 |
| Brockmeyer, NH | 1 |
| van Noesel, C | 1 |
| Potthoff, A | 1 |
| Prins, JM | 1 |
| Kreuter, A | 1 |
| Price, KA | 1 |
| Cohen, EE | 1 |
| Sher, DJ | 1 |
| Thotakura, V | 1 |
| Balboni, TA | 1 |
| Norris, CM | 1 |
| Lorch, J | 1 |
| Goguen, LA | 1 |
| Annino, DJ | 1 |
| Fox, PA | 1 |
| Shah, SM | 1 |
| Drage, MG | 1 |
| Lichtman, AH | 1 |
| Bernard, HU | 1 |
| Speck, NM | 1 |
| Ribalta, JC | 1 |
| Focchi, J | 1 |
| Costa, RR | 1 |
| Kesselring, F | 1 |
| Freitas, VG | 1 |
| Saxena, A | 1 |
| Yashar, C | 1 |
| Taylor, DD | 1 |
| Gercel-Taylor, C | 1 |
| Singh, S | 2 |
| Chhipa, RR | 1 |
| Vijayakumar, MV | 1 |
| Bhat, MK | 2 |
| Gábor, B | 1 |
| Imdahl, A | 1 |
| György, L | 1 |
| Pál, O | 1 |
| Georgiev, D | 1 |
| Karag'ozov, I | 1 |
| Velev, M | 1 |
| Makaveeva, V | 1 |
| Upadhyay, AK | 1 |
| Ajay, AK | 1 |
| Niccoli, V | 1 |
| Serrao, L | 1 |
| Hatch, KD | 1 |
| Stone, KM | 1 |
| Dungar, CF | 1 |
| Wilkinson, EJ | 1 |
| Klutke, JJ | 1 |
| Bergman, A | 1 |
| Husseinzadeh, N | 1 |
| Guoth, JG | 1 |
| Jayawardena, DS | 1 |
| Davila, GW | 1 |
| Shroyer, KR | 1 |
| Kotoulas, IG | 1 |
| Cardamakis, E | 1 |
| Relakis, K | 1 |
| Diamantis, A | 1 |
| Papathanasiou, Z | 1 |
| Korantzis, A | 1 |
| Mantouvalos, C | 1 |
| Stefanon, B | 1 |
| Pallucca, A | 1 |
| Merola, M | 1 |
| Bandieramonte, G | 1 |
| Beutner, KR | 1 |
| Ferenczy, A | 1 |
| Holmes, MM | 1 |
| Weaver, SH | 1 |
| Vermillion, ST | 1 |
| Lakatosh, VP | 1 |
| Syed, TA | 1 |
| Qureshi, ZA | 1 |
| Ahmad, SA | 1 |
| Ali, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of the Clinical Value of a Docetaxel, Cisplatin and 5-fluorouracil (DCF) Strategy Adapted to Patients for the Management of Metastatic or Locally Advanced Anal Resistant Radiochemotherapy Squamous Cell Anal Carcinoma.[NCT02402842] | Phase 2 | 70 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
| Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial[NCT02615860] | 560 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
| A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons[NCT02437851] | Phase 2 | 16 participants (Actual) | Interventional | 2015-04-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for fluorouracil and HPV Infection
| Article | Year |
|---|---|
Anal squamous intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; A | 2013 |
Anal cancer treatment: current status and future perspectives.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; C | 2015 |
Advances in the Management of Anal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Cisplatin; Female; Flu | 2016 |
Current treatment options for metastatic head and neck cancer.
Topics: Alcohol Drinking; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; | 2012 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cido | 2012 |
Established and potential strategies against papillomavirus infections.
Topics: Aminoquinolines; Antimetabolites; Antiviral Agents; Cidofovir; Cytosine; Drug Design; Fluorouracil; | 2004 |
[Human papillomavirus infections in pregnancy].
Topics: Adolescent; Adult; Cryosurgery; Electrocoagulation; Female; Fluorouracil; Humans; Interferons; Laser | 1994 |
Clinical appearance and treatment strategies for human papillomavirus: a gynecologic perspective.
Topics: Condylomata Acuminata; Female; Fluorouracil; Genital Diseases, Female; Humans; Interferons; Laser Th | 1995 |
Human papillomavirus infection and genital warts: update on epidemiology and treatment.
Topics: Condylomata Acuminata; Cryotherapy; Female; Fluorouracil; Humans; Interferons; Laser Therapy; Male; | 1995 |
Therapeutic approaches to genital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites; Antiviral Agents; Condylomata Acuminata; C | 1997 |
8 trials available for fluorouracil and HPV Infection
| Article | Year |
|---|---|
Randomised controlled trial of 1% and 5% 5-fluorouracil creams compared with 90% trichloroacetic acid solution for anogenital wart treatment.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Anti-Infective Agents; Combined Modality | 2020 |
Anti-Telomerase CD4
Topics: Adaptive Immunity; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; A | 2020 |
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Doce | 2019 |
Interferon as an adjuvant treatment for genital condyloma acuminatum.
Topics: Adolescent; Adult; Combined Modality Therapy; Condylomata Acuminata; Female; Fluorouracil; Genital N | 1995 |
Treatment with 5-fluorouracil of 35 patients with clinical or subclinical HPV infection of the vagina.
Topics: Administration, Topical; Adult; Antimetabolites, Antineoplastic; Female; Fluorouracil; Follow-Up Stu | 1996 |
A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.
Topics: Administration, Intravaginal; Adolescent; Adult; Antimetabolites, Antineoplastic; Double-Blind Metho | 1999 |
[The treatment of benign processes of the cervix uteri associated with papillomavirus infection in women who have not given birth].
Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Fluorouracil; Glycerol; Huma | 1999 |
Management of intravaginal warts in women with 5-fluorouracil (1%) in vaginal hydrophilic gel: a placebo-controlled double-blind study.
Topics: Administration, Intravaginal; Adolescent; Adult; Antimetabolites; Double-Blind Method; Female; Fluor | 2000 |
40 other studies available for fluorouracil and HPV Infection
| Article | Year |
|---|---|
Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Topics: Adult; Feasibility Studies; Female; Fluorouracil; Humans; Imiquimod; Papillomaviridae; Papillomaviru | 2023 |
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluoroura | 2020 |
Chemotherapy, "Lighting the Fire" or "Releasing the Brakes" in Metastatic Anal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Catheter A | 2017 |
HPV-related squamous cell carcinoma in a neovagina after male-to-female gender confirmation surgery.
Topics: Biopsy; Carboplatin; Carcinoma, Squamous Cell; Colostomy; Fatal Outcome; Female; Fluorouracil; Human | 2018 |
Brown papules on the penis.
Topics: Administration, Topical; Adult; Antimetabolites, Antineoplastic; Biopsy; Bowen's Disease; Fluorourac | 2018 |
Towards risk-stratified induction regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Clinical Trials, | 2019 |
The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiothe | 2019 |
Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, West | 2013 |
Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Topics: Antimetabolites; Antineoplastic Agents; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Do | 2013 |
DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Cisplatin; Disease-Free | 2013 |
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2014 |
[The significance of physical status of human papillomavirus type 16 for predicting the effectiveness of invasive cervical cancer treatment].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Comparative Effectiv | 2013 |
KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
Topics: Aged; Antineoplastic Agents; Anus Neoplasms; Axons; Carcinoma, Squamous Cell; Class I Phosphatidylin | 2014 |
Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Biomarkers, Tumor; Carcinoma, Squamo | 2015 |
Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relatio | 2014 |
Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorouracil; Human Papillomavirus | 2014 |
Review of anal cancer patients at the Ottawa hospital.
Topics: Adult; Aged; Aged, 80 and over; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neo | 2015 |
Perianal infection of highly oncogenic human papilloma virus: how to prevent from cancer? Case report.
Topics: Anal Canal; Anus Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Hemorrhoidectomy; He | 2015 |
Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Cyclin- | 2015 |
Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Anus | 2015 |
Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck Cancer.
Topics: Bridged-Ring Compounds; Carcinoma, Squamous Cell; Disease-Free Survival; Fluorouracil; Follow-Up Stu | 2016 |
Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Caspase 8; | 2016 |
Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata.
Topics: Administration, Topical; Anesthetics, Local; Condylomata Acuminata; Drug Therapy, Combination; Fluor | 2008 |
Cutaneous human papillomavirus in head and neck squamous cell carcinomas.
Topics: Aged; Alcohol Drinking; Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Carbopl | 2009 |
Commentary: Anal cancer - the benefits of evidence-based treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemotherapy, Adjuvant; Cisplatin; D | 2009 |
Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy.
Topics: Adenocarcinoma; Biopsy; Carcinoma in Situ; DNA, Viral; Female; Fluorouracil; Histocytochemistry; Hum | 2010 |
[In reference to the article: "Neck dissection following chemoradiation for node positive head and neck carcinomas" by Thariat et al. Cancer Radiother 2009;13:758-770].
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplat | 2010 |
Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men.
Topics: Administration, Topical; Adult; Aged; AIDS-Related Opportunistic Infections; Antimetabolites, Antine | 2010 |
Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men.
Topics: Administration, Topical; Adult; Aged; AIDS-Related Opportunistic Infections; Antimetabolites, Antine | 2010 |
Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men.
Topics: Administration, Topical; Adult; Aged; AIDS-Related Opportunistic Infections; Antimetabolites, Antine | 2010 |
Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men.
Topics: Administration, Topical; Adult; Aged; AIDS-Related Opportunistic Infections; Antimetabolites, Antine | 2010 |
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.
Topics: Aged; Albumin-Bound Paclitaxel; Albumins; Antibodies, Monoclonal; Antineoplastic Combined Chemothera | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carb | 2012 |
Low-dose 5-fluorouracil adjuvant in laser therapy for HPV lesions in immunosuppressed patients and cases of difficult control.
Topics: Administration, Intravaginal; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Combined Mod | 2004 |
Cellular response to chemotherapy and radiation in cervical cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line | 2005 |
DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Carboplatin; Caspase 9; Caspases; | 2006 |
[HPV-infection in esophageal cancer as possible predictive factor after neoadjuvant therapy].
Topics: Antineoplastic Agents; Blotting, Southern; Chemotherapy, Adjuvant; Cisplatin; DNA, Viral; Esophageal | 2006 |
[Three cases of vaginal adenosis after topical 5-fluorouracil therapy for vaginal HPV-associated lesions].
Topics: Administration, Intravaginal; Antimetabolites, Antineoplastic; Female; Fluorouracil; Humans; Papillo | 2006 |
Gadd45alpha does not modulate the carboplatin or 5-fluorouracil-induced apoptosis in human papillomavirus-positive cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Carboplatin; C | 2007 |
Vaginal columnar cell metaplasia. An acquired adenosis associated with topical 5-fluorouracil therapy.
Topics: Adult; Epithelial Cells; Epithelium; Female; Fluorouracil; Humans; Metaplasia; Middle Aged; Papillom | 1995 |
Subclinical cervicovaginal human papillomavirus infections associated with cervical condylomata and dysplasia. Treatment outcomes.
Topics: Adolescent; Adult; Condylomata Acuminata; Female; Fluorouracil; Genital Diseases, Female; Humans; La | 1994 |
Topical 5-fluorouracil in the treatment of cervical human papillomavirus infection.
Topics: Administration, Topical; Adult; Biopsy; DNA, Viral; Female; Fluorouracil; Humans; In Situ Hybridizat | 1996 |
Peoscopic diagnosis of flat condyloma and penile intraepithelial neoplasia. IV. Urethral reservoir.
Topics: Adolescent; Adult; Carcinoma in Situ; Condylomata Acuminata; Endothelium; Female; Fluorouracil; Huma | 1996 |